Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 47 entries
View as:

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)

Phase: N/A Priority: Normal
NCT ID: NCT01453634 Org: User:
Start: 01/31/13 End: 07/31/13 Due: 07/31/14

A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02692781 Org: User:
Start: 02/29/16 End: 12/15/16 Due: 12/15/17

A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01909479 Org: User:
Start: 06/30/13 End: 08/31/18 Due: 08/31/19

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Phase: N/A Priority: Normal
NCT ID: NCT00743002 Org: User:
Start: 08/31/08 End: 12/31/09 Due: 12/31/10

Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.

Phase: N/A Priority: Normal
NCT ID: NCT03762408 Org: User:
Start: 12/15/17 End: 05/29/20 Due: 05/29/21

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01766336 Org: User:
Start: 01/31/13 End: 08/31/15 Due: 08/31/16

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Phase: N/A Priority: Normal
NCT ID: NCT02919800 Org: User:
Start: 01/22/17 End: 02/21/18 Due: 02/21/19

A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia

Phase: N/A Priority: Normal
NCT ID: NCT01791725 Org: User:
Start: 09/30/13 End: 06/30/14 Due: 06/30/15

MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)

Phase: N/A Priority: Normal
NCT ID: NCT01225666 Org: User:
Start: 08/31/10 End: 04/30/12 Due: 04/30/13

A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1

Phase: N/A Priority: Normal
NCT ID: NCT00239187 Org: User:
Start: 09/30/05 End: 01/31/07 Due: 01/31/08

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

Phase: N/A Priority: Normal
NCT ID: NCT02274623 Org: User:
Start: 12/31/14 End: 03/17/17 Due: 03/17/18

Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00384098 Org: User:
Start: 09/30/06 End: 05/31/07 Due: 05/31/08

Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02418767 Org: User:
Start: 01/31/15 End: 06/30/15 Due: 06/30/16

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

Phase: N/A Priority: Normal
NCT ID: NCT03297398 Org: User:
Start: 02/21/18 End: 06/10/19 Due: 06/10/20

Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients

Phase: N/A Priority: Normal
NCT ID: NCT04063644 Org: User:
Start: 05/30/19 End: 12/22/20 Due: 12/22/21

MOD-4023 Study in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01060722 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)

Phase: N/A Priority: Normal
NCT ID: NCT00557791 Org: User:
Start: 11/30/09 End: 07/31/12 Due: 07/31/13

Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT03355651 Org: User:
Start: 03/09/15 End: 03/03/17 Due: 03/03/18

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00259753 Org: User:
Start: 07/31/05 End: 12/31/07 Due: 12/31/08

Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5

Phase: N/A Priority: Normal
NCT ID: NCT00722384 Org: User:
Start: 08/31/04 End: 12/31/07 Due: 12/31/08

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01674010 Org: User:
Start: 08/31/12 End: 06/30/14 Due: 06/30/15

Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03660800 Org: User:
Start: 08/20/18 End: 01/22/19 Due: 01/22/20

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

Phase: N/A Priority: Normal
NCT ID: NCT00499590 Org: User:
Start: 08/31/07 End: 05/31/09 Due: 05/31/10

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Phase: N/A Priority: Normal
NCT ID: NCT01592500 Org: User:
Start: 02/29/12 End: 07/31/15 Due: 07/31/16

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT05543928 Org: User:
Start: 01/31/23 End: 06/19/24 Due: 06/19/25